Track market-moving stories before they get noisy

Posted by Defense World Staff on Jul 20th, 2026

Bessemer Group Inc. grew its stake in Lincoln National Corporation (NYSE:LNC – Free Report) by 25.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 203,973 shares of the financial services provider’s stock after purchasing an additional 41,345 shares during the period. Bessemer Group Inc. owned approximately 0.11% of Lincoln National worth $7,241,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. JPL Wealth Management LLC acquired a new stake in Lincoln National in the 3rd quarter valued at $29,000. V Square Quantitative Management LLC acquired a new position in Lincoln National during the fourth quarter worth $31,000. Transamerica Financial Advisors LLC acquired a new position in Lincoln National during the fourth quarter worth $32,000. NBT Bank N A NY lifted its holdings in shares of Lincoln National by 2,051.1% during the first quarter. NBT Bank N A NY now owns 968 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 923 shares during the period. Finally, Los Angeles Capital Management LLC bought a new position in shares of Lincoln National during the fourth quarter valued at $34,000. 72.81% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling In other Lincoln National news, EVP Craigt T. Beazer sold 30,000 shares of the company’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $34.45, for a total transaction of $1,033,500.00. Following the completion of the sale, the executive vice president owned 103,906 shares in the company, valued at approximately $3,579,561.70. The trade was a 22.40% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.03% of the company’s stock.

Lincoln National Stock Performance Lincoln National stock opened at $42.26 on Monday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.65. Lincoln National Corporation has a 1 year low of $32.18 and a 1 year high of $46.82. The company has a market cap of $8.08 billion, a PE ratio of 4.90, a PEG ratio of 2.99 and a beta of 1.17. The company’s 50-day moving average is $36.73 and its two-hundred day moving average is $37.58.

Lincoln National (NYSE:LNC – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The financial services provider reported $1.66 EPS for the quarter, topping the consensus estimate of $1.58 by $0.08. The company had revenue of $4.87 billion during the quarter, compared to analysts’ expectations of $4.93 billion. Lincoln National had a net margin of 9.17% and a return on equity of 18.07%. Lincoln National’s revenue was up 13.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.60 EPS. Equities analysts anticipate that Lincoln National Corporation will post 7.73 earnings per share for the current year.

Lincoln National Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Monday, August 3rd. Shareholders of record on Friday, July 10th will be issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date of this dividend is Friday, July 10th. Lincoln National’s payout ratio is currently 20.88%.

Wall Street Analysts Forecast Growth Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company upped their target price on shares of Lincoln National from $44.00 to $47.00 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Morgan Stanley cut their price target on shares of Lincoln National from $43.00 to $40.00 and set an “overweight” rating for the company in a report on Thursday, May 21st. Bank of America reduced their price target on shares of Lincoln National from $41.00 to $37.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 14th. Weiss Ratings cut shares of Lincoln National from a “buy (b-)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Finally, Keefe, Bruyette & Woods upped their price objective on shares of Lincoln National from $44.00 to $46.00 and gave the stock an “outperform” rating in a research note on Monday, July 13th. Six equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $44.79.

Get Our Latest Analysis on Lincoln National

Lincoln National Profile (Free Report)

Lincoln National Corporation, doing business as Lincoln Financial Group, is a diversified financial services holding company focused on providing retirement, insurance, and wealth management solutions in the United States and select international markets. Headquartered in Radnor, Pennsylvania, the company operates through several business segments, including Retirement Plan Services, Life Insurance, and Group Protection. Its offerings are designed to help individuals, families, and institutions plan and prepare for their financial futures.

The Retirement Plan Services segment delivers recordkeeping, administrative services, and investment management for defined contribution and defined benefit plans.

Featured Stories Five stocks we like better than Lincoln National Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Lincoln National Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lincoln National and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBessemer Group Inc. Has $11.67 Million Stake in CSW Industrials, Inc. $CSW

NEXT HEADLINE »Bessemer Group Inc. Boosts Stake in Credo Technology Group Holding Ltd. $CRDO

Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.

Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.

This site is protected by reCAPTCHA.

Coinbase CEO Armstrong Dismisses Chamath’s Bitcoin Mining Warning: Will Price Suffer?

https://solana.com/

Solana has seen an influx of over $26 million in assets bridged from other blockchains over the past week, according to data from SolanaFloor. This activity highlights ongoing cross-chain capital flows into Solana, even as the current figure is lower than previous peaks like the $760 million recorded in September 2025. The Solana network, noted for its high on-chain activity and decentralized exchange (DEX) volume leadership, continues to draw interest despite the relatively modest inflow. The recent asset movement may indicate sustained interest in Solana’s capabilities, potentially influenced by its competitive transaction speed and cost advantages.

Advertisement

Key Takeaways The movement of over $26 million in assets to Solana suggests continued interest in the blockchain, although lower than previous peaks. Solana’s features, including high transaction speeds and active DEX volume, are likely contributing factors to the cross-chain inflows. Market pricing implies a moderate increase in Solana’s price potential, with scenarios supporting a rise to $90 being considered. What to Watch Watch whether the inflow trend accelerates or decelerates, which could impact Solana’s price trajectory. Key upcoming developments include potential announcements about Solana-based financial products or significant upgrades, which could further influence market expectations. Markets will also be monitoring macroeconomic indicators, such as interest rate changes, that could affect broader cryptocurrency market conditions.

Get live prediction-market analysis, powered by Vera. Sign up for Vera.

Term Structure

Contract Odds Δ since publish Volume 24h August 1 2026 4.5% — — View market → August 1 2026 0.3% — — View market → August 1 2026 0.1% — — View market → August 1 2026 1.1% — — View market → August 1 2026 0.7% — — View market → August 1 2026 0.5% — — View market → August 1 2026 1.5% — — View market → August 1 2026 0.8% — — View market → August 1 2026 3.8% — — View market → August 1 2026 0.1% — — View market → August 1 2026 0.8% — — View market → August 1 2026 0.1% — — View market → August 1 2026 34% — — View market → August 1 2026 0.1% — — View market → August 1 2026 0.1% — — View market →

Polymarket Whale Turns $1.9M $TRUMP Win Into $1.2M World Cup Loss

Crypto may not be struggling because the technology has stopped developing. According to Galaxy Digital CEO Mike Novogratz, the bigger problem right now is that the market has lost the attention of speculative traders.

The traders who once chased Solana and other high-flying crypto assets are now looking for excitement elsewhere. “Every young kid that used to buy Solana is buying Hynix or some memory company,” Novogratz said. He pointed to the growing interest in semiconductor stocks and other hot trades.

He also added sports betting, same-day options and Korean stocks as areas that have absorbed much of the speculative energy. This energy once flowed into crypto.

Crypto Has Lost Its “Vibe”Novogratz compared the current market to the previous gold and silver bubble, saying crypto has experienced a similar speculative peak.

“That’s what tops look like,” he said, while stressing that a market topping does not mean the asset class disappears. For him, the current crypto mood is simple: “Meh.”

“People just aren’t as excited about it because there’s other things to be excited about,” Novogratz said.

Still, he does not believe Bitcoin’s long-term story has been broken. He said Bitcoin price could hold around $60,000. However, reaching $80,000 and eventually $100,000 would require three major catalysts. These are the CLARITY Act passing, Federal Reserve rate cuts and a renewed base of buyers.

He does not expect rate cuts this year. However, he sees the CLARITY Act as roughly a 60/40 or possibly two-thirds chance of passing. His base case is that Bitcoin remains between $60,000 and $80,000 for the rest of the year. If it breaks above $80,000, $100,000 could become the next major resistance.

The Technology Is Still Being BuiltDespite the lack of hype, Novogratz believes crypto infrastructure is continuing to develop behind the scenes.

“I’m literally doing deals with five or six, hopefully, big traditional institutions to help build infrastructure,” he said. He pointed to automatic settlement and the ability to transfer value over the internet as technologies that could eventually be used across financial markets.

Crypto also remains more important in many overseas markets than in the United States. Traditional financial services in the U.S. are already highly developed.

The Next Crypto Phase Could Be DifferentOverall, his broader message is that the speculative frenzy may have moved elsewhere for now. However, the underlying technology has not gone away.

The next major crypto phase, he said, may not be driven purely by hype and leveraged trading. Instead, the infrastructure being built today could eventually create a more sustainable market. One that brings real financial institutions and users into the ecosystem even after the speculative crowd has moved on.

Story Ends Here

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

Read the Next News

PUMP Hits Two-Month High on Ansem Position DisclosurePumpfun's native token $PUMP climbed to its strongest level since May 12 on Monday after crypto trader Ansem (@blknoiz06) disclosed a new position in the asset. According to BeInCrypto, Ansem entered the trade at $0.001675, with on-chain data showing he deployed 1,500 SOL, worth roughly $115,000, to acquire the position. The disclosure moved markets, with PUMP posting gains of more than 21% on the day and 31% over the trailing week.

The move also drew in larger leveraged bets. On-chain tracker Lookonchain noted that one trader opened a 10x long on 764 million PUMP tokens worth $1.53 million shortly after Ansem's buy was spotted, with a liquidation price set at $0.0016194.

Ansem's Solana Thesis Places Pumpfun at the CentreThe trade is tied to a broader thesis. Ansem argued that Solana will dominate retail on-chain activity in this cycle and that Pumpfun stands to be the primary beneficiary if that plays out. He also suggested a large user airdrop could reignite activity on the platform, drawing comparisons with the Jito and Jupiter distributions of late 2023, which drove significant trading volumes across the Solana ecosystem.

The broader context adds weight to the call. Ansem has previously stated that Pumpfun generates roughly $440 million in annualised revenue, yet PUMP trades at a fully diluted valuation of around $1.4 billion, a fraction of what comparable platforms command. He has argued that the gap reflects a trust deficit with users rather than a weakness in the underlying business, and that delivering a long-promised airdrop to early participants could begin to close it.

Monday's rally also extended gains that began on Sunday, when attention from a viral meme coin drove PUMP from around $0.0016 to $0.0019. The combination of that momentum and Ansem's disclosed buy pushed the token to an intraday high of $0.00207, its best print in over two months.

As with any influencer-driven move, the durability of the rally will depend on whether the underlying thesis attracts sustained conviction or fades once the initial attention cycle passes. Pumpfun has yet to announce a formal airdrop plan.

Sources:
BeInCrypto: Pump.fun Token Hits 2-Month High as Ansem Reveals PUMP Buy
crypto.news: Ansem says token buybacks cannot fix weak crypto valuations

Posted by Defense World Staff on Jul 20th, 2026

California Public Employees Retirement System cut its holdings in shares of Microchip Technology Incorporated (NASDAQ:MCHP – Free Report) by 2.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,280,223 shares of the semiconductor company’s stock after selling 30,775 shares during the quarter. California Public Employees Retirement System owned about 0.24% of Microchip Technology worth $82,715,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. EFG International AG purchased a new stake in shares of Microchip Technology during the 4th quarter valued at $29,000. Miller Capital Partners Inc. acquired a new stake in Microchip Technology in the 4th quarter valued at $29,000. Reflection Asset Management purchased a new position in Microchip Technology in the fourth quarter valued at about $33,000. Garton & Associates Financial Advisors LLC acquired a new position in shares of Microchip Technology during the fourth quarter worth about $33,000. Finally, Caitong International Asset Management Co. Ltd boosted its position in shares of Microchip Technology by 4,663.6% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 524 shares of the semiconductor company’s stock worth $33,000 after buying an additional 513 shares during the period. Hedge funds and other institutional investors own 91.51% of the company’s stock.

Key Stories Impacting Microchip Technology Here are the key news stories impacting Microchip Technology this week:

Positive Sentiment: KeyCorp raised long-term earnings expectations for Microchip Technology, forecasting FY2027 EPS of $3.00 and FY2028 EPS of $3.83, both above current consensus. This points to improving fundamentals and supports a more constructive outlook for NASDAQ:MCHP. Positive Sentiment: Recent coverage highlighted Microchip’s strong earnings surprise history and the potential to beat estimates again, reinforcing investor confidence ahead of the next report. Positive Sentiment: Another bullish note pointed to Microchip’s 35.3% year-to-date gain being driven by inventory recovery, stronger bookings, and AI data center demand, all of which may continue to support the stock. Neutral Sentiment: KeyCorp also provided quarterly estimates for FY2027 and FY2028 periods, but these updates were primarily forecast revisions rather than new company guidance or a major business announcement. Analyst Upgrades and Downgrades Several equities research analysts have issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and set a $125.00 price objective on shares of Microchip Technology in a report on Wednesday, May 13th. JPMorgan Chase & Co. lifted their target price on Microchip Technology from $95.00 to $120.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. Susquehanna raised their price objective on Microchip Technology from $95.00 to $120.00 and gave the stock a “positive” rating in a research note on Friday, May 8th. Zacks Research raised shares of Microchip Technology from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 12th. Finally, Barclays boosted their price objective on shares of Microchip Technology from $80.00 to $105.00 and gave the company an “equal weight” rating in a research report on Monday, May 11th. Four analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $100.10.

Read Our Latest Research Report on MCHP

Microchip Technology Price Performance MCHP stock opened at $80.96 on Monday. The firm’s 50-day moving average is $92.15 and its two-hundred day moving average is $80.59. The company has a market capitalization of $43.96 billion, a price-to-earnings ratio of 385.54, a price-to-earnings-growth ratio of 0.82 and a beta of 1.74. Microchip Technology Incorporated has a 52 week low of $48.52 and a 52 week high of $105.91. The company has a current ratio of 2.09, a quick ratio of 1.18 and a debt-to-equity ratio of 0.85.

Microchip Technology (NASDAQ:MCHP – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The semiconductor company reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.07. Microchip Technology had a net margin of 4.88% and a return on equity of 10.87%. The business had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.26 billion. During the same period last year, the firm posted $0.11 earnings per share. The business’s revenue was up 35.1% on a year-over-year basis. Microchip Technology has set its Q1 2027 guidance at 0.670-0.710 EPS. On average, analysts forecast that Microchip Technology Incorporated will post 2.69 earnings per share for the current fiscal year.

Microchip Technology Announces Dividend The company also recently announced a quarterly dividend, which was paid on Friday, June 5th. Investors of record on Friday, May 22nd were issued a dividend of $0.455 per share. This represents a $1.82 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Friday, May 22nd. Microchip Technology’s payout ratio is presently 866.67%.

Insider Buying and Selling at Microchip Technology In related news, COO Richard J. Simoncic sold 5,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $97.52, for a total transaction of $487,600.00. Following the completion of the sale, the chief operating officer directly owned 130,508 shares of the company’s stock, valued at $12,727,140.16. This represents a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO James Eric Bjornholt sold 3,667 shares of Microchip Technology stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $90.87, for a total transaction of $333,220.29. Following the completion of the transaction, the chief financial officer owned 28,573 shares in the company, valued at approximately $2,596,428.51. This trade represents a 11.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 553,302 shares of company stock valued at $49,673,635 in the last ninety days. Company insiders own 1.79% of the company’s stock.

Microchip Technology Profile (Free Report)

Microchip Technology Inc is a semiconductor company headquartered in Chandler, Arizona, that designs, develops and supplies a broad portfolio of embedded control and analog semiconductors. Its product lineup centers on microcontrollers (including the well-known PIC family), digital signal controllers and associated development tools and software, along with a range of mixed-signal and analog devices, nonvolatile memory, power management, timing, interface, wireless and security products. The company also provides integrated hardware and software solutions intended to simplify embedded design and accelerate time to market for OEMs and contract manufacturers.

Microchip’s products are used across a wide range of end markets, including automotive, industrial automation, consumer electronics, communications, aerospace and defense, and Internet of Things (IoT) applications.

Further Reading Five stocks we like better than Microchip Technology Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Microchip Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microchip Technology and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Sells 98,679 Shares of Nasdaq, Inc. $NDAQ

NEXT HEADLINE »Nathan Coe Sells 70,158 Shares of Auto Trader Group (LON:AUTO) Stock

On-Chain, But Not Risk-Free: Inside Atlas System’s Smart Cycle Architecture

GBP/JPY wavers around 218.50, with bears contained above previous highs at 218.00.

The Pound picks uop across the board with markets awaiting Andrew Burnham's nomination as next PM.

The British Pound (GBP) is trading practically flat against the Japanese Yen (JPY) on Monday, with the GBP/JPY pair wavering around 218.50, holding comfortably above previous highs at the 218.00 area, and with last week’s long.term high at 219.63 within a short distance.

The Pound Sterling remains moderately bid with investors bracing for the nomination of former Mayor of Manchester, Andy Burnham, as the next Prime Minister. Burnham pledged in an interview with The Times newspaper a 10-year plan to “rewire” the UK after having assured markets that he will pursue responsible fiscal policy.

In Japan, markets are closed for the Marine Day holiday, which is keeping market volatility low and the Japanese Yen moving within tight ranges so far.

Technical Analysis: Bulls remain focused on the 219.63 high

GBP/JPY trades at 218.69, retaining a bullish near-term bias with price action supported by an ascending trendline from late June lows. The 4-hour Relative Strength Index (14) around 58 suggests underlying buying interest, while the slightly negative Moving Average Convergence Divergence (MACD) reading hints at a shallow corrective pressure rather than a decisive reversal.

Bulls remain capped below session highs at 218.85, although the main focus remains on last week's high, at 219.63. Above here, the next target might be at the 127.2% Fibonacci extension of the July 10-15 rally, at 220.45.

On the downside, initial support is seen at the confluence between trendline support, now around 218.15, and Friday's trading floor, in the area of 218. A bearish reversal below here would expose the July 7 and 10 lows, near 216.40.

(The technical analysis of this story was written with the help of an AI tool. Know more.)

Pound Sterling Price Today The table below shows the percentage change of British Pound (GBP) against listed major currencies today. British Pound was the strongest against the Euro.

USDEURGBPJPYCADAUDNZDCHFUSD0.07%-0.09%0.02%0.06%-0.24%-0.09%0.09%EUR-0.07%-0.13%-0.06%-0.03%-0.31%-0.19%0.00%GBP0.09%0.13%0.09%0.12%-0.18%-0.04%0.13%JPY-0.02%0.06%-0.09%0.05%-0.25%-0.08%0.06%CAD-0.06%0.03%-0.12%-0.05%-0.30%-0.13%0.00%AUD0.24%0.31%0.18%0.25%0.30%0.16%0.34%NZD0.09%0.19%0.04%0.08%0.13%-0.16%0.15%CHF-0.09%-0.01%-0.13%-0.06%-0.00%-0.34%-0.15% The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the British Pound from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent GBP (base)/USD (quote).

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Hub Group Inc. (NASDAQ:HUBG) and certain of the Company’s senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.

If you invested in Hub Group, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/hub-group-class-action-lawsuit.

Key Details of the HUBG ($HUBG) Class Action:

Lead Plaintiff Deadline: August 28, 2026Alleged Misconduct: Securities fraud relating to Hub Group’s financial results, revenue recognition, accounting of costs, internal controls, and prospects for/drivers of growthLargest Stock Drop: February 6, 2026 – 18% Stock DropCourt: U.S. District Court for the Northern District of IllinoisFiling Law Firm: Bleichmar Fonti & Auld (“BFA Law”)Action: Contact BFA Law to discuss your rights Investors have until August 28, 2026, to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Hub Group securities. The class action is pending in the U.S. District Court for the Northern District of Illinois. It is captioned Lawler v. Hub Group, Inc., No. 1:26-cv-07596.

Why is Hub Group Being Sued for Securities Fraud?

Hub Group is a transportation and logistics freight carrier that provides trucking and related services to operators across the supply chain. Hub Group services a customer base extending across various industries, including retail, consumer products, automotive, and durable goods, and reports to be one of the largest freight transportation providers in North America. 

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements concerning the premature and incorrect revenue recognition of certain transactions, the understatement of purchased transportation costs and accounts payable, the effectiveness of internal controls, and the Hub Group’s drivers of financial results and growth.

Why did Hub Group’s Stock Drop?

On February 5, 2026, Hub Group announced that the Company’s financial statements for the first three quarters of 2025 should not be relied upon and would be restated due to “an error that resulted in the understatement of purchased transportation costs and accounts payable in the first nine months of 2025.” Hub Group revealed that its reports for those quarters “were in each case materially misstated due to the aforementioned error and should no longer be relied upon” and that “the Company [wa]s also continuing to assess the effectiveness of its disclosure controls and procedures and internal control over financial reporting and appropriate remediation steps.”  Hub Group also estimated that “[t]he total amount of the reduction to accounts payable and purchased transportation costs related to this issue that was recorded during these periods is $77 million.”

This news caused the price of Hub Group stock to decline roughly 18%, from $51.33 per share at close on February 5, 2026, to $41.96 per share at close on February 6, 2026.

On May 12, 2026, Hub Group announced that it had “identified certain transactions that were prematurely or incorrectly recognized or not adequately supported,” causing its 2023 and 2024 annual reports filed with the SEC to be “materially misstated,” such that they “should no longer be relied upon.”  Hub Group did not quantify the expected misstatement, although it “expect[ed] to conclude that it did not maintain effective disclosure controls and procedures and internal control over financial reporting for each of the years ended December 31, 2024 and 2023.”

This news caused the price of Hub Group stock to decline a further 13%, from $41.86 per share at close on May 11, 2026, to $36.62 per share at close on May 12, 2026.

Click here for more information: https://www.bfalaw.com/cases/hub-group-class-action-lawsuit.

What Can You Do?

If you invested in Hub Group, you may have legal options and are encouraged to submit your information to the firm.

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.

Submit your information by visiting:

https://www.bfalaw.com/cases/hub-group-class-action-lawsuit

Or contact:
Adam McCall
[email protected]
212.789.3619

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.” 

Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

For more information about BFA and its attorneys, please visit https://www.bfalaw.com.

https://www.bfalaw.com/cases/hub-group-class-action-lawsuit

Attorney advertising. Past results do not guarantee future outcomes.

Cantillon Capital Management LLC lowered its position in shares of Entegris, Inc. (NASDAQ:ENTG – Free Report) by 11.9% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,166,428 shares of the semiconductor company’s stock after selling 292,725 shares during the quarter. Entegris comprises 1.7% of Cantillon Capital Management LLC’s investment portfolio, making the stock its 27th biggest holding. Cantillon Capital Management LLC owned about 1.42% of Entegris worth $253,992,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Invesco Ltd. boosted its position in shares of Entegris by 183.5% during the 3rd quarter. Invesco Ltd. now owns 3,167,857 shares of the semiconductor company’s stock valued at $292,900,000 after purchasing an additional 2,050,473 shares in the last quarter. Norges Bank bought a new stake in Entegris in the fourth quarter worth approximately $158,669,000. Duquesne Family Office LLC acquired a new position in Entegris in the second quarter valued at approximately $132,741,000. Rafferty Asset Management LLC boosted its holdings in shares of Entegris by 64.4% during the 2nd quarter. Rafferty Asset Management LLC now owns 1,970,734 shares of the semiconductor company’s stock worth $158,940,000 after buying an additional 771,650 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of Entegris by 31.2% during the 2nd quarter. Bank of America Corp DE now owns 3,031,048 shares of the semiconductor company’s stock worth $244,454,000 after buying an additional 720,467 shares in the last quarter.

Entegris Stock Performance NASDAQ ENTG opened at $138.74 on Monday. The company has a quick ratio of 2.05, a current ratio of 3.21 and a debt-to-equity ratio of 0.91. Entegris, Inc. has a 52 week low of $67.97 and a 52 week high of $186.94. The business has a 50 day moving average price of $146.53 and a 200-day moving average price of $131.42. The company has a market cap of $21.16 billion, a price-to-earnings ratio of 80.20, a P/E/G ratio of 1.62 and a beta of 1.31.

Entegris (NASDAQ:ENTG – Get Free Report) last issued its earnings results on Thursday, April 30th. The semiconductor company reported $0.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.75 by $0.11. Entegris had a return on equity of 11.45% and a net margin of 8.18%.The company had revenue of $811.90 million for the quarter, compared to analysts’ expectations of $808.72 million. During the same period last year, the business earned $0.67 EPS. Entegris’s quarterly revenue was up 5.0% compared to the same quarter last year. Entegris has set its Q2 2026 guidance at 0.760-0.840 EPS. As a group, equities analysts expect that Entegris, Inc. will post 3.65 earnings per share for the current fiscal year.

Entegris Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 19th. Shareholders of record on Wednesday, July 29th will be paid a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Wednesday, July 29th. Entegris’s dividend payout ratio (DPR) is 23.12%.

Analyst Ratings Changes Several research firms have recently weighed in on ENTG. Oppenheimer reiterated an “outperform” rating and issued a $160.00 price objective on shares of Entegris in a research note on Friday, May 1st. Zacks Research lowered shares of Entegris from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 23rd. Needham & Company LLC raised their price target on shares of Entegris from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, April 30th. Wall Street Zen raised shares of Entegris from a “buy” rating to a “strong-buy” rating in a research note on Sunday, July 12th. Finally, Weiss Ratings upgraded shares of Entegris from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, May 6th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Entegris presently has a consensus rating of “Moderate Buy” and an average target price of $164.22.

View Our Latest Research Report on ENTG

Insider Transactions at Entegris In related news, SVP Olivier Blachier sold 2,000 shares of the company’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $140.04, for a total value of $280,080.00. Following the sale, the senior vice president owned 34,897 shares in the company, valued at $4,886,975.88. This represents a 5.42% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Susan G. Rice sold 19,893 shares of the company’s stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $132.84, for a total transaction of $2,642,586.12. Following the completion of the sale, the senior vice president owned 69,038 shares in the company, valued at $9,171,007.92. This represents a 22.37% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 44,466 shares of company stock valued at $6,186,624. Corporate insiders own 0.53% of the company’s stock.

About Entegris (Free Report)

Entegris, Inc is a leading provider of advanced materials and process control solutions for the semiconductor and other high-technology industries. The company develops and supplies a broad portfolio of products designed to ensure purity and reliability throughout the manufacturing process, helping customers address critical contamination and yield challenges.

Entegris’s product offerings include high-purity chemicals and specialty materials, liquid and gas filtration and purification systems, and sophisticated wafer and chip handling solutions.

See Also Five stocks we like better than Entegris Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks Want to see what other hedge funds are holding ENTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Entegris, Inc. (NASDAQ:ENTG – Free Report).

Receive News & Ratings for Entegris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entegris and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 20th, 2026

Cantillon Capital Management LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 11.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,710,896 shares of the medical research company’s stock after selling 230,248 shares during the period. IQVIA comprises approximately 1.9% of Cantillon Capital Management LLC’s holdings, making the stock its 23rd largest position. Cantillon Capital Management LLC owned about 1.01% of IQVIA worth $291,776,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ameliora Wealth Management Ltd. purchased a new position in shares of IQVIA during the 4th quarter worth approximately $25,000. International Assets Investment Management LLC acquired a new position in IQVIA during the fourth quarter worth $27,000. Gilpin Wealth Management LLC purchased a new position in IQVIA in the fourth quarter worth $27,000. CrossGen Wealth LLC acquired a new stake in IQVIA in the fourth quarter valued at $28,000. Finally, Activest Wealth Management boosted its position in shares of IQVIA by 590.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the medical research company’s stock worth $31,000 after purchasing an additional 118 shares in the last quarter. Institutional investors and hedge funds own 89.62% of the company’s stock.

Analyst Ratings Changes Several research analysts have weighed in on IQV shares. Mizuho upped their target price on shares of IQVIA from $215.00 to $230.00 and gave the stock an “outperform” rating in a research report on Monday, July 13th. Morgan Stanley reissued an “equal weight” rating and set a $200.00 price target (down from $225.00) on shares of IQVIA in a research note on Wednesday, June 17th. Weiss Ratings upgraded IQVIA from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday. Wall Street Zen downgraded IQVIA from a “buy” rating to a “hold” rating in a research note on Saturday, June 27th. Finally, Evercore reiterated an “outperform” rating and set a $185.00 target price on shares of IQVIA in a research report on Wednesday, April 8th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $225.71.

Get Our Latest Analysis on IQV

IQVIA Stock Performance Shares of IQV stock opened at $206.26 on Monday. The firm has a market cap of $34.42 billion, a P/E ratio of 25.56, a PEG ratio of 1.85 and a beta of 1.20. The firm’s 50-day simple moving average is $185.04 and its 200-day simple moving average is $187.88. IQVIA Holdings Inc. has a 1-year low of $154.50 and a 1-year high of $247.04. The company has a debt-to-equity ratio of 2.20, a current ratio of 0.75 and a quick ratio of 0.75.

IQVIA (NYSE:IQV – Get Free Report) last released its quarterly earnings data on Tuesday, May 5th. The medical research company reported $2.90 EPS for the quarter, topping analysts’ consensus estimates of $2.83 by $0.07. IQVIA had a return on equity of 30.50% and a net margin of 8.33%.The business had revenue of $4.15 billion during the quarter, compared to the consensus estimate of $4.10 billion. During the same period in the prior year, the firm posted $2.70 EPS. The business’s revenue for the quarter was up 8.4% on a year-over-year basis. IQVIA has set its FY 2026 guidance at 12.650-12.950 EPS. As a group, equities analysts forecast that IQVIA Holdings Inc. will post 11.57 EPS for the current year.

IQVIA announced that its board has initiated a stock repurchase program on Thursday, May 7th that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the medical research company to purchase up to 6.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

IQVIA Company Profile (Free Report)

IQVIA (NYSE: IQV) is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. The company combines clinical research capabilities with large-scale health data and analytics to support drug development, regulatory reporting, commercial strategy and real‑world evidence generation. IQVIA traces its current form to the combination of Quintiles and IMS Health announced in 2016 and subsequently rebranded as IQVIA, bringing together long-established clinical research operations and extensive healthcare information assets.

IQVIA’s principal activities include outsourced clinical development services (acting as a contract research organization for phases I–IV), real‑world evidence and observational research, regulatory and safety services, and a suite of technology platforms that enable data integration, analytics and operational management.

Featured Stories Five stocks we like better than IQVIA Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Free Report).

Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBank of New York Mellon Corp Boosts Holdings in First Solar, Inc. $FSLR

Posted by Defense World Staff on Jul 20th, 2026

Fifth Third Bancorp grew its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 7,433.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,568 shares of the biopharmaceutical company’s stock after acquiring an additional 9,441 shares during the quarter. Fifth Third Bancorp’s holdings in Alnylam Pharmaceuticals were worth $3,166,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also made changes to their positions in the company. First Horizon Corp boosted its holdings in shares of Alnylam Pharmaceuticals by 20.7% in the 4th quarter. First Horizon Corp now owns 163 shares of the biopharmaceutical company’s stock valued at $65,000 after buying an additional 28 shares during the period. Yousif Capital Management LLC lifted its holdings in Alnylam Pharmaceuticals by 1.8% in the fourth quarter. Yousif Capital Management LLC now owns 1,676 shares of the biopharmaceutical company’s stock worth $666,000 after acquiring an additional 29 shares during the last quarter. Daiwa Securities Group Inc. lifted its holdings in Alnylam Pharmaceuticals by 0.3% in the second quarter. Daiwa Securities Group Inc. now owns 12,941 shares of the biopharmaceutical company’s stock worth $4,220,000 after acquiring an additional 35 shares during the last quarter. Golden State Wealth Management LLC lifted its holdings in Alnylam Pharmaceuticals by 100.0% in the fourth quarter. Golden State Wealth Management LLC now owns 72 shares of the biopharmaceutical company’s stock worth $29,000 after acquiring an additional 36 shares during the last quarter. Finally, Everpar Advisors LLC boosted its stake in Alnylam Pharmaceuticals by 6.3% in the fourth quarter. Everpar Advisors LLC now owns 620 shares of the biopharmaceutical company’s stock valued at $247,000 after acquiring an additional 37 shares during the period. 92.97% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Alnylam Pharmaceuticals In related news, Director David E. I. Pyott sold 3,830 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $299.18, for a total transaction of $1,145,859.40. Following the transaction, the director owned 1,582 shares in the company, valued at $473,302.76. This trade represents a 70.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.86% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In Several analysts recently issued reports on the company. Chardan Capital reissued a “buy” rating and issued a $425.00 price target on shares of Alnylam Pharmaceuticals in a report on Wednesday, March 25th. Morgan Stanley upped their price objective on Alnylam Pharmaceuticals from $370.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Friday, July 10th. Weiss Ratings upgraded Alnylam Pharmaceuticals from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, May 4th. Bank of America lowered their price target on shares of Alnylam Pharmaceuticals from $460.00 to $410.00 and set a “buy” rating for the company in a research report on Tuesday, July 14th. Finally, HC Wainwright increased their price objective on shares of Alnylam Pharmaceuticals from $470.00 to $485.00 and gave the stock a “buy” rating in a report on Monday, July 13th. Two analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Alnylam Pharmaceuticals currently has an average rating of “Moderate Buy” and an average target price of $455.31.

Get Our Latest Analysis on ALNY

Alnylam Pharmaceuticals Price Performance Shares of ALNY opened at $267.47 on Monday. The firm has a market capitalization of $35.71 billion, a price-to-earnings ratio of 73.08 and a beta of 0.27. The company has a debt-to-equity ratio of 0.94, a quick ratio of 3.06 and a current ratio of 3.13. Alnylam Pharmaceuticals, Inc. has a one year low of $266.43 and a one year high of $495.55. The stock’s fifty day moving average is $294.16 and its 200-day moving average is $320.56.

Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The biopharmaceutical company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $0.87 by $1.12. The business had revenue of $1.17 billion during the quarter, compared to the consensus estimate of $1.12 billion. Alnylam Pharmaceuticals had a net margin of 11.72% and a return on equity of 85.76%. The company’s quarterly revenue was up 96.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.44) earnings per share. Equities analysts anticipate that Alnylam Pharmaceuticals, Inc. will post 7.26 EPS for the current year.

Alnylam Pharmaceuticals Profile (Free Report)

Alnylam Pharmaceuticals, Inc (NASDAQ: ALNY) is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics. Founded to translate the scientific discovery of RNAi into new medicines, Alnylam applies small interfering RNA (siRNA) technology to silence disease-causing genes. The company develops therapies designed to provide durable disease modification by targeting underlying genetic drivers across a range of rare and more prevalent conditions.

Alnylam has advanced multiple siRNA-based products into commercialization, initially using lipid nanoparticle delivery and more recently employing GalNAc-conjugate chemistry to enable targeted delivery to the liver with subcutaneous dosing.

Further Reading Five stocks we like better than Alnylam Pharmaceuticals Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Alnylam Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alnylam Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEChildress Capital Advisors LLC Sells 4,046 Shares of Amazon.com, Inc. $AMZN

NEXT HEADLINE »VeriSign, Inc. $VRSN Shares Sold by Bank of New York Mellon Corp

Shiba Inu, the second-largest meme coin by market value, saw a sharp reduction in exchange outflows over the past 24 hours. Data shows that this key metric dropped by approximately 65%, raising questions about the strength of investor accumulation and overall market sentiment toward SHIB.

Exchange flows and investor sentimentExchange outflows track the amount of SHIB withdrawn from centralized trading platforms. Typically, sustained outflows suggest that investors are moving tokens into self-custody or long-term storage, which reduces the immediately available supply and may reflect a bullish outlook.

A sudden decline in outflows, as observed recently, can signal waning investor confidence or a slowdown in accumulation. Despite this reduction, netflows remain negative, with more SHIB leaving exchanges than entering them, a condition often interpreted as a positive indicator for price stability.

At the time of measurement, exchange netflows were negative and reserves on trading platforms continued to decrease, a trend that has established a long-term bullish bias among some market participants.

Mini dictionary: Exchange outflows, the total amount of cryptocurrency withdrawn from centralized exchanges in a specified timeframe. High outflows can signal accumulation and confidence, while declining outflows may indicate slowing interest in self-custody or long-term holding.

The marked decrease in outflows suggests that, while SHIB is still leaving exchanges on balance, the intensity of this trend is tapering off.

Market impact and network activityThe pattern of shrinking SHIB reserves stored on exchanges has persisted in recent months, reducing the overall liquidity that could be sold at short notice. This shrinkage, measured both in token count and USD equivalent, typically points to ongoing investor accumulation.

However, the latest 65% drop in daily outflows is significant. When the pace of withdrawals slows, it may reflect either caution among long-term holders or declining engagement from large investors and active traders. In cryptocurrency markets, not only the metric’s direction but also its rate of change is closely watched for shifts in sentiment.

MetricPrevious SessionCurrentChangeSHIB Daily OutflowsHighLow-65%NetflowsNegativeNegativeStableExchange ReservesDecreasingDecreasingOngoing trendTransactional activity on the Shiba Inu network remains steady, which means that overall usage is not declining sharply. Nevertheless, without an uptick in withdrawals, it could prove challenging for bulls to generate the buying pressure needed to support a strong price recovery, especially during periods of increased market volatility.

Outlook remains cautiousThe drop in SHIB exchange outflows stands out as a potential warning sign. If this stagnation in accumulation continues, Shiba Inu may struggle to build the momentum necessary for a significant rally. While negative netflows and shrinking reserves still lend support to a bullish long-term thesis, short-term dynamics suggest that investors are proceeding with caution amid uncertainty in the wider crypto market.

Despite fewer tokens being deposited onto exchanges, the pronounced fall in outflows indicates that many traders may be hesitating to move their assets off trading platforms in the immediate term.

Analysts will likely monitor upcoming data closely to determine whether SHIB can regain the momentum in exchange withdrawals required to underpin further gains.

For now, the evolving balance between exchange outflows, reserves, and netflows continues to shape short-term sentiment surrounding Shiba Inu.

Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.

Shiba Inu’s burn rate surged over the past 24 hours after community members permanently removed more than 13 million SHIB tokens from circulation.

According to Shibburn data, a total of 13.2 million Shiba Inu were burned in the past day, permanently reducing the token’s circulating supply. The burns were completed across 13 separate transactions, with the largest single burn accounting for the majority of the destroyed tokens.

The biggest transaction occurred yesterday when an unidentified user transferred 9.7 million SHIB from the CEX.IO exchange to the official dead wallet. Meanwhile, the second-largest burn took place just hours before press time, eliminating approximately 1.2 million SHIB from circulation.

Shiba Inu Burn Activity Accelerates Sharply The latest burn marks a significant increase compared with activity recorded over the previous week, during which daily burns generally remained below 7 million SHIB.

Following the latest spike in burns, Shibburn data shows that the 24-hour burn rate soared by 131.2%. The recent activity also lifted longer-term burn totals. Weekly burns have now reached 45.44 million SHIB, while the monthly burn count has climbed to 269.9 million SHIB. 

Shiba Inu Burn Since the launch of the Shiba Inu ecosystem, the community has permanently destroyed 410,840,414,408,454 SHIB (410.84 trillion) through 21,216 burn transactions. That figure represents 41.08% of Shiba Inu’s original 1 quadrillion-token supply, leaving about 58.92% of the total supply still in circulation. 

SHIB Price Remains Under Selling Pressure Despite the sharp increase in token burns, SHIB continues to trade under bearish pressure. At the time of writing, Shiba Inu was down 0.23% over the past 24 hours, trading at $0.000004143. The token has also declined 1.36% over the past seven days and 12.31% over the last month.

Furthermore, SHIB remains 1.13% lower on a month-to-date basis, leaving the token with only 11 days to recover and turn its monthly performance positive. It continues to rank outside the top 30 and currently stands as the 33rd-biggest token globally, with a market cap of $2.43 billion. 

Meanwhile, growing exchange inflows continue to offset the positive impact of the latest burn activity. According to CryptoQuant data, approximately 12.6 billion SHIB flowed into cryptocurrency exchanges over the past 24 hours. 

Consequently, Shiba Inu’s exchange reserve increased to 86.32 trillion SHIB, suggesting that more holders may be positioning their tokens for potential selling, which could continue to weigh on the asset’s near-term price performance. 

DisClamier: This content is informational and should not be considered financial advice. The views expressed in this article may include the author's personal opinions and do not reflect The Crypto Basic opinion. Readers are encouraged to do thorough research before making any investment decisions. The Crypto Basic is not responsible for any financial losses.

Posted by Defense World Staff on Jul 20th, 2026

Broderick Brian C grew its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 8.5% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 18,656 shares of the pharmaceutical company’s stock after buying an additional 1,454 shares during the period. Vertex Pharmaceuticals makes up about 1.5% of Broderick Brian C’s investment portfolio, making the stock its 24th largest holding. Broderick Brian C’s holdings in Vertex Pharmaceuticals were worth $8,331,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in VRTX. Nordea Investment Management AB boosted its position in shares of Vertex Pharmaceuticals by 23.8% during the fourth quarter. Nordea Investment Management AB now owns 447,169 shares of the pharmaceutical company’s stock valued at $202,612,000 after buying an additional 86,084 shares during the last quarter. Cooper Financial Group increased its holdings in Vertex Pharmaceuticals by 130.2% in the 4th quarter. Cooper Financial Group now owns 5,341 shares of the pharmaceutical company’s stock worth $2,421,000 after buying an additional 3,021 shares in the last quarter. Assenagon Asset Management S.A. raised its position in Vertex Pharmaceuticals by 9.1% in the 4th quarter. Assenagon Asset Management S.A. now owns 832,853 shares of the pharmaceutical company’s stock worth $377,582,000 after buying an additional 69,150 shares during the last quarter. Allworth Financial LP raised its position in Vertex Pharmaceuticals by 414.1% in the 4th quarter. Allworth Financial LP now owns 14,036 shares of the pharmaceutical company’s stock worth $6,363,000 after buying an additional 11,306 shares during the last quarter. Finally, Sandro Wealth Management LLC bought a new position in Vertex Pharmaceuticals during the 4th quarter valued at about $1,436,000. Institutional investors own 90.96% of the company’s stock.

Insider Transactions at Vertex Pharmaceuticals In other Vertex Pharmaceuticals news, CMO Carmen Bozic sold 6,988 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $450.00, for a total transaction of $3,144,600.00. Following the completion of the sale, the chief marketing officer directly owned 26,088 shares of the company’s stock, valued at approximately $11,739,600. This represents a 21.13% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Ourania Tatsis sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $524.99, for a total transaction of $787,485.00. Following the completion of the transaction, the executive vice president owned 45,321 shares in the company, valued at $23,793,071.79. The trade was a 3.20% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 18,874 shares of company stock worth $8,707,966. 0.20% of the stock is currently owned by corporate insiders.

Vertex Pharmaceuticals Stock Performance VRTX stock opened at $485.65 on Monday. Vertex Pharmaceuticals Incorporated has a fifty-two week low of $362.50 and a fifty-two week high of $533.67. The business’s 50-day moving average is $462.54 and its two-hundred day moving average is $459.00. The company has a market cap of $123.26 billion, a price-to-earnings ratio of 28.80, a P/E/G ratio of 2.11 and a beta of 0.29.

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) last released its quarterly earnings results on Monday, May 4th. The pharmaceutical company reported $4.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.24 by $0.23. The business had revenue of $2.99 billion during the quarter, compared to the consensus estimate of $2.99 billion. Vertex Pharmaceuticals had a return on equity of 23.86% and a net margin of 35.51%.The business’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same period in the previous year, the company posted $4.06 EPS. Equities analysts predict that Vertex Pharmaceuticals Incorporated will post 17.01 earnings per share for the current year.

Wall Street Analyst Weigh In A number of analysts have recently issued reports on the stock. Truist Financial raised their price target on shares of Vertex Pharmaceuticals from $542.00 to $560.00 and gave the company a “buy” rating in a report on Monday, July 13th. Weiss Ratings raised shares of Vertex Pharmaceuticals from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday. Canaccord Genuity Group lowered their price objective on shares of Vertex Pharmaceuticals from $437.00 to $436.00 and set a “hold” rating on the stock in a research report on Tuesday, May 5th. Wall Street Zen cut shares of Vertex Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Sunday, June 28th. Finally, Sanford C. Bernstein dropped their target price on shares of Vertex Pharmaceuticals from $577.00 to $572.00 and set an “outperform” rating on the stock in a report on Tuesday, May 5th. Twenty-two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $559.61.

Get Our Latest Stock Report on Vertex Pharmaceuticals

Vertex Pharmaceuticals Company Profile (Free Report)

Vertex Pharmaceuticals Inc is a Boston-based biotechnology company focused on the discovery, development and commercialization of therapies for serious diseases. Founded in 1989, Vertex built its reputation on research-driven drug development and is best known for its work in cystic fibrosis (CF), where its portfolio of small-molecule CFTR modulators transformed standards of care for many people with the disease. The company operates research and development, manufacturing and commercial organizations and serves patients and healthcare systems in multiple international markets.

Vertex’s marketed products center on CFTR modulators that target the underlying cause of cystic fibrosis rather than just treating symptoms.

Featured Stories Five stocks we like better than Vertex Pharmaceuticals Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Vertex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINETop Biotech Stocks Worth Watching – July 19th

NEXT HEADLINE »Danaher Corporation $DHR Shares Acquired by Broderick Brian C

HomeEarnings AnalysisConsumer Staples Analysis

SummaryBoston Beer Company is rated “Hold” due to fair valuation and weak technicals ahead of Q2 earnings.SAM faces demographic headwinds, negative FY26 EPS growth, and a challenging operating environment despite a strong balance sheet.Gross margin improved to 49.3% amid volume declines, but litigation expenses and high short interest add risk.Valuation is justified by a mid-teens P/E and $10 normalized EPS, with resistance at $185–$190 and bearish technical trends. vicm/iStock Unreleased via Getty Images

Shares of The Boston Beer Company, Inc. (SAM) skyrocketed from 2017 to April 2021, rising from $129 nine years ago to $1350 during the final wave of the COVID-19 pandemic. But the stock is back down to earth, trading in its 2010s range amid

9.48K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Quantum computing harnesses the rules of quantum mechanics to process information differently than classical computers. Instead of bits locked as zeros or ones, quantum systems use qubits that can exist in superposition -- holding multiple states at once. In artificial intelligence (AI), quantum computing stands out as a major frontier because hybrid quantum-classical systems stand to accelerate machine learning, improve generative models, and tackle problems in areas such as logistics or neural network design.

Management consulting firm McKinsey & Company estimates that quantum computing could unlock up to $2.7 trillion in global economic value by 2035. Prominent use cases span drug discovery, portfolio optimization and risk modeling, and supply chain efficiencies.

Early value will likely come from hybrid approaches that pair quantum processors with classical AI and high-performance computing. Against this backdrop, I see some parallels between IonQ's (IONQ 0.91%) quantum computing approach and Palantir Technologies' (PLTR 1.40%) ascent to dominating the AI software landscape.

Image source: Getty Images.

What makes IonQ unique? IonQ's approach to quantum computing is to build its systems around trapped ions -- individual atoms held in place and manipulated with lasers. This approach aims to deliver identical qubits with exceptionally high operational accuracy and flexibility, allowing any qubit to interact directly with one another.

Rather than focusing purely on hardware, IonQ has built a full-stack quantum platform spanning computing, networking, sensing, and security. The company has achieved this through a series of acquisitions that added photonic interconnects for scalable networking, advanced electronic control techniques to facilitate manufacturing, and quantum-safe communications capabilities.

The company's revenue growth has been striking: IonQ generated $130 million in 2025, representing 202% growth over the prior year and making it the first public quantum business to surpass $100 million in annual revenue. In the first quarter of 2026, IonQ brought in $64.7 million in sales and guided between $260 million and $270 million in revenue for the full year as remaining performance obligations (RPO) grew 554% to $470 million.

Today's Change

(

-0.91

%) $

-0.32

Current Price

$

34.78

Analyzing IonQ's valuation profile IonQ boasts a market capitalization of $13.2 billion. At the high end of its 2026 revenue guidance, this implies a forward price-to-sales (P/S) multiple of 49 -- well above typical technology hardware or software peers.

IONQ Cash and Short Term Investments (Quarterly) data by YCharts

While the company maintains ample liquidity on its balance sheet, IonQ remains consistently unprofitable. Heavy ongoing investments in research, scaling systems, and integrating acquisitions have driven ongoing EBITDA losses -- eating into the company's runway.

What makes IonQ the next Palantir? Palantir turned big data analytics into mission-critical software for enterprises and government agencies alike. IonQ is attempting something analogous by creating an end-to-end quantum AI ecosystem. I think IonQ echoes Palantir's early trajectory as a specialized platform company tackling a transformative domain featuring both government and commercial traction, rapid top-line expansion, and a defensible technological edge.

Indeed, IonQ's valuation is undeniably stretched relative to near-term fundamentals. Nevertheless, the combination of the company's technological differentiation and its progress toward a comprehensive platform could make the premium more justified for investors with a long-term horizon.

With that said, IonQ stock is not a low-risk buy at current levels. While the company's unique profile and growth trajectory may render the valuation reasonable rather than completely detached from reality, investors should be convinced that quantum computing will deliver on its promise before blindly pouring into the stock.

Posted by Defense World Staff on Jul 20th, 2026

California Public Employees Retirement System cut its position in Ciena Corporation (NYSE:CIEN – Free Report) by 1.3% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 237,900 shares of the communications equipment provider’s stock after selling 3,067 shares during the quarter. California Public Employees Retirement System owned about 0.17% of Ciena worth $92,360,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Elyxium Wealth LLC purchased a new position in Ciena during the 4th quarter valued at about $2,747,810,000. Corient Private Wealth LLC lifted its holdings in Ciena by 30,114.5% in the 4th quarter. Corient Private Wealth LLC now owns 2,870,677 shares of the communications equipment provider’s stock worth $671,365,000 after purchasing an additional 2,861,176 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in Ciena by 53.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 4,051,625 shares of the communications equipment provider’s stock worth $947,554,000 after acquiring an additional 1,404,132 shares during the last quarter. Atreides Management LP bought a new stake in Ciena during the 2nd quarter valued at approximately $102,705,000. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of Ciena by 2,174.2% during the third quarter. Arrowstreet Capital Limited Partnership now owns 1,143,855 shares of the communications equipment provider’s stock worth $166,625,000 after buying an additional 1,093,557 shares during the last quarter. Institutional investors own 91.99% of the company’s stock.

Analyst Upgrades and Downgrades A number of equities research analysts recently weighed in on the company. Argus set a $650.00 target price on Ciena in a research report on Friday, June 5th. Citigroup lifted their price target on Ciena from $345.00 to $658.00 and gave the company a “buy” rating in a report on Monday, May 18th. JPMorgan Chase & Co. lifted their target price on Ciena from $380.00 to $550.00 and gave the company an “overweight” rating in a research note on Thursday, April 16th. Barclays increased their target price on Ciena from $372.00 to $607.00 and gave the company an “overweight” rating in a research note on Friday, June 5th. Finally, Rosenblatt Securities increased their price objective on Ciena from $350.00 to $720.00 and gave the stock a “buy” rating in a report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $530.56.

View Our Latest Stock Analysis on Ciena

Ciena Stock Down 0.2% NYSE:CIEN opened at $373.72 on Monday. The firm’s 50 day simple moving average is $495.15 and its 200 day simple moving average is $404.91. Ciena Corporation has a one year low of $83.20 and a one year high of $637.51. The company has a market cap of $52.90 billion, a PE ratio of 124.57 and a beta of 1.27. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.73 and a quick ratio of 2.11.

Ciena (NYSE:CIEN – Get Free Report) last issued its earnings results on Thursday, June 4th. The communications equipment provider reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.46 by $0.18. Ciena had a return on equity of 18.15% and a net margin of 7.87%.The business had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the previous year, the company posted $0.42 earnings per share. The firm’s revenue for the quarter was up 39.5% on a year-over-year basis. On average, research analysts anticipate that Ciena Corporation will post 5.4 earnings per share for the current year.

Insider Transactions at Ciena In other Ciena news, SVP Brodie Gage sold 1,200 shares of the business’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $466.10, for a total value of $559,320.00. Following the transaction, the senior vice president owned 42,741 shares of the company’s stock, valued at approximately $19,921,580.10. The trade was a 2.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Gary B. Smith sold 2,952 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $468.83, for a total value of $1,383,986.16. Following the completion of the transaction, the chief executive officer owned 254,886 shares in the company, valued at approximately $119,498,203.38. The trade was a 1.14% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 21,627 shares of company stock worth $10,974,985. Company insiders own 0.58% of the company’s stock.

Ciena Company Profile (Free Report)

Ciena Corporation (NYSE: CIEN) is a global supplier of telecommunications networking equipment, software and services. The company develops high-capacity optical transport systems and packet-optical platforms that enable service providers, cloud operators and large enterprises to build, manage and scale their networks. Ciena’s product portfolio includes coherent optical solutions, packet networking platforms and a suite of network automation software designed to optimize bandwidth, reduce latency and simplify network operations.

In addition to hardware offerings, Ciena provides professional services and support, including network design, implementation and ongoing maintenance.

See Also Five stocks we like better than Ciena Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Ciena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ciena and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBessemer Group Inc. Has $6.03 Million Position in Iridium Communications Inc $IRDM

NEXT HEADLINE »AlTi Global Inc. Buys 941 Shares of Eli Lilly and Company $LLY

California Public Employees Retirement System decreased its holdings in shares of Verisk Analytics, Inc. (NASDAQ:VRSK – Free Report) by 14.9% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 314,982 shares of the business services provider’s stock after selling 55,071 shares during the period. California Public Employees Retirement System owned about 0.24% of Verisk Analytics worth $59,768,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. NewEdge Advisors LLC boosted its stake in Verisk Analytics by 1.1% in the first quarter. NewEdge Advisors LLC now owns 4,232 shares of the business services provider’s stock valued at $1,259,000 after acquiring an additional 44 shares during the period. Nicolet Advisory Services LLC grew its holdings in shares of Verisk Analytics by 3.5% during the third quarter. Nicolet Advisory Services LLC now owns 1,377 shares of the business services provider’s stock valued at $339,000 after purchasing an additional 47 shares during the last quarter. Legacy Advisors LLC raised its position in shares of Verisk Analytics by 3.8% during the 4th quarter. Legacy Advisors LLC now owns 1,295 shares of the business services provider’s stock worth $290,000 after purchasing an additional 48 shares during the period. Essex Bank boosted its holdings in shares of Verisk Analytics by 0.4% during the fourth quarter. Essex Bank now owns 12,388 shares of the business services provider’s stock valued at $2,771,000 after acquiring an additional 53 shares during the period. Finally, Net Worth Advisory Group grew its position in shares of Verisk Analytics by 5.1% during the fourth quarter. Net Worth Advisory Group now owns 1,151 shares of the business services provider’s stock worth $257,000 after acquiring an additional 56 shares during the last quarter. 90.00% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Verisk Analytics In related news, Director Bruce Edward Hansen sold 2,336 shares of Verisk Analytics stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $174.99, for a total transaction of $408,776.64. Following the transaction, the director directly owned 15,868 shares of the company’s stock, valued at $2,776,741.32. The trade was a 12.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Samuel G. Liss sold 4,671 shares of Verisk Analytics stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $182.21, for a total value of $851,102.91. Following the transaction, the director directly owned 69,098 shares in the company, valued at approximately $12,590,346.58. The trade was a 6.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 16,507 shares of company stock valued at $2,925,710. Corporate insiders own 0.52% of the company’s stock.

Verisk Analytics Stock Performance Shares of NASDAQ:VRSK opened at $200.68 on Monday. The company has a 50 day moving average of $179.05 and a 200-day moving average of $190.31. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 10.42. The firm has a market cap of $26.29 billion, a P/E ratio of 30.54, a P/E/G ratio of 2.24 and a beta of 0.69. Verisk Analytics, Inc. has a twelve month low of $155.94 and a twelve month high of $304.29.

Verisk Analytics (NASDAQ:VRSK – Get Free Report) last announced its earnings results on Wednesday, April 29th. The business services provider reported $1.82 EPS for the quarter, topping the consensus estimate of $1.76 by $0.06. The firm had revenue of $782.60 million for the quarter, compared to analysts’ expectations of $771.62 million. Verisk Analytics had a negative return on equity of 2,405.75% and a net margin of 29.34%.The firm’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.73 earnings per share. Verisk Analytics has set its FY 2026 guidance at 7.450-7.750 EPS. As a group, analysts anticipate that Verisk Analytics, Inc. will post 7.65 earnings per share for the current fiscal year.

Verisk Analytics Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend was Monday, June 15th. Verisk Analytics’s payout ratio is currently 30.44%.

Analyst Upgrades and Downgrades A number of research firms recently weighed in on VRSK. Weiss Ratings cut shares of Verisk Analytics from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, May 14th. Morgan Stanley set a $235.00 target price on shares of Verisk Analytics in a research report on Thursday, April 30th. Royal Bank Of Canada restated an “outperform” rating and issued a $230.00 price target on shares of Verisk Analytics in a research note on Monday, March 30th. Rothschild & Co Redburn set a $185.00 price target on Verisk Analytics and gave the company a “neutral” rating in a report on Thursday, June 18th. Finally, JPMorgan Chase & Co. boosted their price objective on Verisk Analytics from $220.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, April 30th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Verisk Analytics has an average rating of “Hold” and an average target price of $234.87.

Read Our Latest Stock Report on VRSK

Verisk Analytics Profile (Free Report)

Verisk Analytics, Inc (NASDAQ: VRSK) is a data analytics and decision‑support provider that helps organizations assess and manage risk. The company supplies data, predictive models and software to customers in insurance, reinsurance, financial services, government, energy and other commercial markets. Its offerings are designed to support underwriting, pricing, claims management, catastrophe modeling, fraud detection and regulatory compliance, enabling clients to make more informed operational and strategic decisions.

Verisk’s product portfolio combines large proprietary datasets with analytics platforms and industry‑specific applications.

See Also Five stocks we like better than Verisk Analytics Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks Want to see what other hedge funds are holding VRSK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Verisk Analytics, Inc. (NASDAQ:VRSK – Free Report).

Receive News & Ratings for Verisk Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verisk Analytics and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 20th, 2026

California Public Employees Retirement System trimmed its holdings in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 2.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 374,509 shares of the aerospace company’s stock after selling 9,816 shares during the quarter. California Public Employees Retirement System owned approximately 0.30% of Leidos worth $58,244,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Longview Financial Advisors Inc. bought a new position in shares of Leidos during the 1st quarter valued at about $26,000. JFS Wealth Advisors LLC grew its position in shares of Leidos by 77.6% during the fourth quarter. JFS Wealth Advisors LLC now owns 151 shares of the aerospace company’s stock valued at $27,000 after purchasing an additional 66 shares in the last quarter. Hantz Financial Services Inc. increased its holdings in shares of Leidos by 94.7% in the fourth quarter. Hantz Financial Services Inc. now owns 148 shares of the aerospace company’s stock worth $27,000 after purchasing an additional 72 shares during the last quarter. Hilton Head Capital Partners LLC bought a new stake in Leidos in the 4th quarter worth approximately $28,000. Finally, Rakuten Securities Inc. raised its holdings in shares of Leidos by 110.5% during the 4th quarter. Rakuten Securities Inc. now owns 160 shares of the aerospace company’s stock worth $29,000 after acquiring an additional 84 shares in the last quarter. 76.12% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades Several equities analysts have commented on the stock. Argus upgraded shares of Leidos to a “strong-buy” rating in a research report on Tuesday, March 31st. TD Cowen lowered their price objective on Leidos from $160.00 to $115.00 and set a “hold” rating for the company in a research note on Tuesday, July 7th. Truist Financial dropped their target price on Leidos from $195.00 to $160.00 and set a “buy” rating for the company in a report on Friday, July 10th. Stifel Nicolaus cut their price objective on shares of Leidos from $205.00 to $193.00 and set a “hold” rating on the stock in a research report on Wednesday, May 6th. Finally, Citigroup reduced their target price on shares of Leidos from $178.00 to $138.00 and set a “buy” rating on the stock in a research note on Wednesday, July 1st. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $163.80.

Check Out Our Latest Stock Analysis on Leidos

Leidos Price Performance Shares of LDOS stock opened at $106.51 on Monday. The company has a market capitalization of $13.40 billion, a P/E ratio of 9.75, a P/E/G ratio of 1.56 and a beta of 0.54. The company’s 50-day simple moving average is $116.09 and its two-hundred day simple moving average is $152.00. Leidos Holdings, Inc. has a one year low of $98.86 and a one year high of $205.77. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.40 and a quick ratio of 1.29.

Leidos (NYSE:LDOS – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The aerospace company reported $3.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.88 by $0.25. Leidos had a return on equity of 31.92% and a net margin of 8.15%.The firm had revenue of $4.40 billion during the quarter, compared to analyst estimates of $4.28 billion. During the same quarter in the previous year, the business earned $2.97 earnings per share. Leidos’s quarterly revenue was up 3.7% on a year-over-year basis. Leidos has set its FY 2026 guidance at 12.100-12.500 EPS. As a group, equities analysts anticipate that Leidos Holdings, Inc. will post 12.3 EPS for the current year.

Leidos Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th were paid a dividend of $0.43 per share. The ex-dividend date was Monday, June 15th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.6%. Leidos’s dividend payout ratio (DPR) is currently 15.75%.

Insider Transactions at Leidos In related news, Director Gary Stephen May sold 1,484 shares of Leidos stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $132.75, for a total transaction of $197,001.00. Following the transaction, the director directly owned 10,137 shares of the company’s stock, valued at $1,345,686.75. This trade represents a 12.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.77% of the stock is currently owned by insiders.

Leidos Company Profile (Free Report)

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.

See Also Five stocks we like better than Leidos Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Purchases 90,385 Shares of Archer Daniels Midland Company $ADM

NEXT HEADLINE »Greenwood Gearhart LLC Acquires 31,619 Shares of iShares Core S&P Mid-Cap ETF $IJH

Posted by Defense World Staff on Jul 20th, 2026

California Public Employees Retirement System trimmed its holdings in Keurig Dr Pepper, Inc (NASDAQ:KDP – Free Report) by 11.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,961,193 shares of the company’s stock after selling 375,964 shares during the period. California Public Employees Retirement System owned 0.22% of Keurig Dr Pepper worth $77,968,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in KDP. Salomon & Ludwin LLC bought a new stake in Keurig Dr Pepper in the 4th quarter valued at $26,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its position in Keurig Dr Pepper by 102,300.0% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,024 shares of the company’s stock worth $34,000 after purchasing an additional 1,023 shares during the period. Rossby Financial LCC boosted its position in Keurig Dr Pepper by 45.1% during the fourth quarter. Rossby Financial LCC now owns 1,090 shares of the company’s stock worth $31,000 after purchasing an additional 339 shares during the period. Activest Wealth Management increased its holdings in shares of Keurig Dr Pepper by 5,642.1% in the fourth quarter. Activest Wealth Management now owns 1,091 shares of the company’s stock valued at $31,000 after purchasing an additional 1,072 shares during the last quarter. Finally, Washington Trust Advisors Inc. bought a new position in shares of Keurig Dr Pepper in the fourth quarter valued at about $31,000. 93.99% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets A number of analysts have recently issued reports on KDP shares. JPMorgan Chase & Co. raised their target price on shares of Keurig Dr Pepper from $32.00 to $33.00 and gave the stock an “overweight” rating in a research note on Friday, April 24th. UBS Group upped their price target on shares of Keurig Dr Pepper from $34.00 to $38.00 and gave the company a “buy” rating in a research note on Thursday. Sanford C. Bernstein set a $39.00 price target on shares of Keurig Dr Pepper in a report on Wednesday, July 8th. Zacks Research downgraded shares of Keurig Dr Pepper from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 18th. Finally, Wells Fargo & Company set a $37.00 price objective on Keurig Dr Pepper in a report on Wednesday, July 1st. Eight analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $33.07.

Get Our Latest Stock Analysis on KDP

Keurig Dr Pepper Price Performance Shares of KDP opened at $30.91 on Monday. The company has a current ratio of 2.31, a quick ratio of 2.12 and a debt-to-equity ratio of 0.72. Keurig Dr Pepper, Inc has a 12 month low of $24.88 and a 12 month high of $35.94. The firm’s 50 day moving average is $30.79 and its 200-day moving average is $28.84. The stock has a market capitalization of $42.05 billion, a PE ratio of 22.90, a P/E/G ratio of 1.41 and a beta of 0.40.

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last issued its quarterly earnings results on Thursday, April 23rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.02. The business had revenue of $3.98 billion during the quarter, compared to analysts’ expectations of $7.23 billion. Keurig Dr Pepper had a return on equity of 10.51% and a net margin of 10.81%.The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.42 earnings per share. Equities research analysts forecast that Keurig Dr Pepper, Inc will post 2.29 EPS for the current year.

Keurig Dr Pepper Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, July 10th. Shareholders of record on Friday, June 26th were issued a $0.23 dividend. The ex-dividend date of this dividend was Friday, June 26th. This represents a $0.92 annualized dividend and a yield of 3.0%. Keurig Dr Pepper’s payout ratio is currently 68.15%.

Keurig Dr Pepper Profile (Free Report)

Keurig Dr Pepper (NASDAQ: KDP) is a North American beverage company formed in July 2018 through the combination of Keurig Green Mountain and Dr Pepper Snapple Group. The company designs, manufactures, markets and distributes a wide range of hot and cold beverages and related equipment, combining Keurig’s single‑serve coffee systems with a large portfolio of carbonated and noncarbonated drink brands. It operates a network of manufacturing, packaging and distribution facilities to supply retail, foodservice and e-commerce channels across its served markets.

The company’s product mix includes single‑serve coffee brewers and coffee pods under the Keurig brand as well as a broad assortment of branded beverages.

See Also Five stocks we like better than Keurig Dr Pepper Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Cuts Stake in United Rentals, Inc. $URI

Posted by Defense World Staff on Jul 20th, 2026

Boston Common Asset Management LLC decreased its position in Vertiv Holdings Co. (NYSE:VRT – Free Report) by 21.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 99,730 shares of the company’s stock after selling 26,806 shares during the period. Vertiv comprises approximately 1.6% of Boston Common Asset Management LLC’s portfolio, making the stock its 12th biggest holding. Boston Common Asset Management LLC’s holdings in Vertiv were worth $24,990,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Sachetta LLC increased its position in Vertiv by 41.4% in the first quarter. Sachetta LLC now owns 123 shares of the company’s stock worth $31,000 after buying an additional 36 shares during the last quarter. Cornerstone Planning Group LLC lifted its position in shares of Vertiv by 60.5% during the 1st quarter. Cornerstone Planning Group LLC now owns 130 shares of the company’s stock valued at $33,000 after buying an additional 49 shares during the last quarter. Vermillion & White Wealth Management Group LLC grew its stake in shares of Vertiv by 58.3% during the 4th quarter. Vermillion & White Wealth Management Group LLC now owns 152 shares of the company’s stock worth $25,000 after acquiring an additional 56 shares during the period. Center for Financial Planning Inc. grew its stake in shares of Vertiv by 554.2% during the 1st quarter. Center for Financial Planning Inc. now owns 157 shares of the company’s stock worth $39,000 after acquiring an additional 133 shares during the period. Finally, Bartlett & CO. Wealth Management LLC purchased a new stake in Vertiv in the 1st quarter worth about $41,000. 89.92% of the stock is owned by institutional investors.

Vertiv Price Performance NYSE:VRT opened at $288.79 on Monday. Vertiv Holdings Co. has a 52-week low of $118.70 and a 52-week high of $379.93. The stock has a fifty day moving average of $320.41 and a 200 day moving average of $270.13. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.15 and a current ratio of 1.49. The firm has a market capitalization of $110.93 billion, a price-to-earnings ratio of 72.56, a P/E/G ratio of 1.25 and a beta of 2.03.

Vertiv (NYSE:VRT – Get Free Report) last released its quarterly earnings results on Wednesday, April 22nd. The company reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.17. Vertiv had a return on equity of 49.90% and a net margin of 14.37%.The firm had revenue of $2.65 billion for the quarter, compared to analysts’ expectations of $2.63 billion. During the same quarter last year, the firm posted $0.64 EPS. The company’s revenue was up 30.1% compared to the same quarter last year. Vertiv has set its Q2 2026 guidance at 1.370-1.430 EPS and its FY 2026 guidance at 6.300-6.400 EPS. On average, research analysts expect that Vertiv Holdings Co. will post 6.38 EPS for the current fiscal year.

Vertiv Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Monday, June 15th were given a $0.0625 dividend. The ex-dividend date was Monday, June 15th. This represents a $0.25 dividend on an annualized basis and a yield of 0.1%. Vertiv’s payout ratio is presently 6.28%.

Key Stories Impacting Vertiv Here are the key news stories impacting Vertiv this week:

Positive Sentiment: Robert W. Baird upgraded Vertiv to strong-buy and initiated/boosted coverage with a $370 price target, citing strong demand tied to data center growth and AI infrastructure spending. Vertiv rated outperform in new coverage at Baird on data center demand Positive Sentiment: Baird’s coverage highlights Vertiv as a key beneficiary of the AI data center power buildout, a theme that investors have been rewarding across infrastructure and cooling names. Vertiv (VRT) Stock: Baird Initiates Coverage With $370 Price Target and Outperform Rating Positive Sentiment: Market commentary continues to group Vertiv among the stocks positioned to gain from the ongoing AI data center power and cooling spending cycle, which supports the long-term earnings outlook. 3 Stocks Riding the AI Data Center Power Buildout in July Neutral Sentiment: RBC Capital trimmed its price target on Vertiv to $418 from $435 but kept an outperform rating, signaling slightly less upside than before while still remaining bullish overall. Benzinga Neutral Sentiment: Leon Cooperman-related portfolio commentary mentioned Vertiv among other holdings, but it did not add a clear new catalyst for the stock. Billionaire Leon Cooperman’s Top 3 Stocks: Buy, Sell or Hold Analyst Ratings Changes A number of brokerages recently issued reports on VRT. Royal Bank Of Canada lowered their price objective on Vertiv from $435.00 to $418.00 and set an “outperform” rating on the stock in a research note on Thursday. Sanford C. Bernstein initiated coverage on shares of Vertiv in a research note on Tuesday, June 9th. They issued an “outperform” rating and a $416.00 target price for the company. Fox Advisors raised shares of Vertiv from a “hold” rating to a “strong-buy” rating in a research report on Thursday, May 21st. Barclays upped their price target on shares of Vertiv from $345.00 to $412.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Finally, BNP Paribas Exane started coverage on shares of Vertiv in a report on Tuesday, April 14th. They issued an “outperform” rating and a $345.00 price objective for the company. Three research analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Vertiv presently has a consensus rating of “Moderate Buy” and an average target price of $342.73.

View Our Latest Analysis on Vertiv

About Vertiv (Free Report)

Vertiv is a global provider of critical digital infrastructure and continuity solutions for data centers, communication networks and commercial and industrial environments. Headquartered in Columbus, Ohio, the company designs, manufactures and services equipment and software that support power availability, thermal management and IT infrastructure management for a broad set of end markets, including hyperscale and enterprise data centers, colocation providers, telecom operators and industrial customers.

The company’s product portfolio includes uninterruptible power supplies (UPS), power distribution units (PDUs), battery and DC power systems, precision cooling and thermal management equipment, racks and enclosures, and integrated modular infrastructure.

Further Reading Five stocks we like better than Vertiv Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks

Receive News & Ratings for Vertiv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vertiv and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBoston Common Asset Management LLC Has $715,000 Position in Accenture PLC $ACN

NEXT HEADLINE »Bank of America Corporation $BAC Shares Sold by Boston Common Asset Management LLC

Posted by Defense World Staff on Jul 20th, 2026

California Public Employees Retirement System decreased its position in shares of Jabil, Inc. (NYSE:JBL – Free Report) by 2.5% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 213,948 shares of the technology company’s stock after selling 5,575 shares during the quarter. California Public Employees Retirement System owned approximately 0.20% of Jabil worth $56,831,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of JBL. Todd Asset Management LLC lifted its holdings in Jabil by 1.9% in the 4th quarter. Todd Asset Management LLC now owns 336,356 shares of the technology company’s stock worth $76,696,000 after purchasing an additional 6,179 shares in the last quarter. Jackson Creek Investment Advisors LLC grew its holdings in Jabil by 386.2% during the 4th quarter. Jackson Creek Investment Advisors LLC now owns 11,290 shares of the technology company’s stock valued at $2,574,000 after buying an additional 8,968 shares in the last quarter. Jefferies Financial Group Inc. bought a new stake in shares of Jabil during the fourth quarter valued at approximately $7,061,000. Allstate Corp raised its position in shares of Jabil by 98.0% during the fourth quarter. Allstate Corp now owns 7,959 shares of the technology company’s stock valued at $1,815,000 after buying an additional 3,939 shares during the last quarter. Finally, National Pension Service lifted its holdings in shares of Jabil by 582.6% in the fourth quarter. National Pension Service now owns 224,903 shares of the technology company’s stock worth $51,282,000 after buying an additional 191,956 shares in the last quarter. Institutional investors own 93.39% of the company’s stock.

Jabil Trading Down 0.1% Shares of JBL stock opened at $300.81 on Monday. The company has a market cap of $31.52 billion, a PE ratio of 37.55, a price-to-earnings-growth ratio of 0.90 and a beta of 1.28. Jabil, Inc. has a 1 year low of $189.60 and a 1 year high of $428.93. The stock’s 50 day simple moving average is $355.90 and its two-hundred day simple moving average is $299.81. The company has a debt-to-equity ratio of 2.17, a current ratio of 0.98 and a quick ratio of 0.66.

Jabil (NYSE:JBL – Get Free Report) last announced its earnings results on Wednesday, June 17th. The technology company reported $3.16 EPS for the quarter, topping analysts’ consensus estimates of $3.10 by $0.06. Jabil had a return on equity of 83.93% and a net margin of 2.57%.The firm had revenue of $8.75 billion during the quarter, compared to analysts’ expectations of $8.61 billion. During the same quarter in the previous year, the business earned $2.55 EPS. The company’s quarterly revenue was up 11.8% on a year-over-year basis. Jabil has set its FY 2026 guidance at 12.700-12.700 EPS and its Q4 2026 guidance at 3.800-4.200 EPS. Research analysts predict that Jabil, Inc. will post 11.71 earnings per share for the current year.

Jabil Announces Dividend The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 2nd. Shareholders of record on Friday, August 14th will be given a dividend of $0.08 per share. The ex-dividend date is Friday, August 14th. This represents a $0.32 dividend on an annualized basis and a yield of 0.1%. Jabil’s payout ratio is 4.00%.

Wall Street Analysts Forecast Growth Several research firms recently weighed in on JBL. Argus set a $475.00 target price on shares of Jabil in a research note on Thursday, June 18th. Raymond James Financial increased their price objective on shares of Jabil from $425.00 to $450.00 and gave the company a “strong-buy” rating in a report on Thursday, June 18th. Weiss Ratings upgraded Jabil from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, July 1st. Wall Street Zen downgraded Jabil from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Finally, The Goldman Sachs Group lifted their price objective on Jabil from $384.00 to $482.00 and gave the stock a “buy” rating in a research note on Thursday, June 18th. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $453.67.

View Our Latest Research Report on Jabil

Insiders Place Their Bets In related news, SVP Gary K. Schick sold 1,000 shares of Jabil stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $340.00, for a total transaction of $340,000.00. Following the completion of the transaction, the senior vice president directly owned 39,843 shares of the company’s stock, valued at approximately $13,546,620. The trade was a 2.45% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Matthew Crowley sold 94 shares of the company’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $345.00, for a total transaction of $32,430.00. Following the transaction, the executive vice president owned 57,536 shares in the company, valued at $19,849,920. The trade was a 0.16% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 1.35% of the company’s stock.

Jabil Profile (Free Report)

Jabil Inc (NYSE: JBL) is a global manufacturing solutions provider specializing in electronic manufacturing services (EMS) and diversified products across a wide range of industries. The company partners with original equipment manufacturers to deliver design engineering, supply chain management, precision manufacturing, and aftermarket services. Jabil’s expertise spans sectors such as healthcare, automotive, clean technology, telecommunications, consumer electronics, and packaging, enabling it to support both high-volume production and complex, mission-critical applications.

Founded in 1966 by William E.

Further Reading Five stocks we like better than Jabil Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks Want to see what other hedge funds are holding JBL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Jabil, Inc. (NYSE:JBL – Free Report).

Receive News & Ratings for Jabil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jabil and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE20,000 Shares in Invesco China Technology ETF $CQQQ Bought by Eurizon Asset Management Hungary Ltd.

NEXT HEADLINE »DekaBank Deutsche Girozentrale Invests $1.07 Million in The Magnum Ice Cream Company N.V. $MICC